Global Brachytherapy Treatment Planning Systems Market Size (2024 - 2029)

The Brachytherapy Treatment Planning Systems Market is anticipated to experience significant growth, driven by the increasing prevalence of cancerous disorders and advancements in healthcare infrastructure. Despite challenges posed by the COVID-19 pandemic, which temporarily impacted treatment protocols, the demand for these systems is expected to rise due to the growing need for effective cancer treatment solutions. The market's expansion is further supported by favorable government initiatives and public-private partnerships aimed at enhancing cancer care. However, challenges such as a shortage of healthcare personnel and cybersecurity concerns may impede growth.

Market Size of Global Brachytherapy Treatment Planning Systems Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Brachytherapy Treatment Planning Systems Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 9.30 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Brachytherapy Treatment Planning Systems Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Brachytherapy Treatment Planning Systems Market Analysis

The Brachytherapy Treatment Planning Systems Market is projected to register a CAGR of 9.30% during the forecast period (2022-2027).

During the pandemic, radiation oncology departments across the country implemented strict guidelines, including temperature checks for patients and staff members, prescreening for COVID-19 symptoms before each patient visit, social distancing in the waiting room, limiting visitors, providing surgical masks to patients, and personal protective equipment for staff members, as part of their respective hospitals' initiatives. As per the study published in January 2021, by Advances in Radiation Oncology, titled ''The Impact of COVID-19 on Brachytherapy During the Pandemic: A Rutgers-Robert Wood Johnson Barnabas Health Multisite Experience, six patients elected to undergo external beam radiation therapy (EBRT) followed by a brachytherapy boost for unfavorable intermediate- and high-risk diseases. Since elective surgeries were canceled within our system during the pandemic, 4 patients were treated with EBRT with or without androgen deprivation therapy (ADT) only. Despite the challenges, the health care system faced during the pandemic, most patients with cancer were safely treated with minor treatment delays and interruptions. Thus, due to the COVID-19 imposed restrictions, the was significantly impacted. However, with the increase in cardiac surgeries, the demand for brachytherapy treatment planning systems is expected to boost the growth of the market.

The increasing prevalence of cancerous disorders is expected to drive the market. The increasing cancer burden is one of the major factors driving the market. According to the International Agency for Research on Cancer (IARC), the global incidence of cancer in 2020 was estimated to be around 19.3 million. This is expected to increase to 24.6 million by the year 2030. Furthermore, breast cancer is among the most common cancer, with around 2.26 million new cases in 2020. Moreover, according to the Globocan 2020 estimates, in 2020, there were approximately 19.3 million cancer cases detected across the globe and some of the most common cancers detected were prostate cancer (7.3%), breast cancer (11.7%), colorectal cancer (10.0%), and lung cancer (11.4%). Further estimates predict a sharp increase of 47% in the caseload in 2040 as compared to 2020. According to the Globocan estimates, there would be 28.4 million new cancer cases diagnosed in 2040 across the globe. With the advent of breakthrough technologies capable of dramatically impacting the industry, the radiation therapy sector is constantly evolving and progressing. The industry is expected to have profitable growth in the next years because of improving healthcare infrastructure and rising healthcare spending.

Furthermore, key participants are focusing on growth opportunities in emerging economies with the development of healthcare infrastructure and growing digital healthcare literacy. Furthermore, favorable government initiatives and the promotion of public-private partnerships in cancer care and radiation therapy will boost product innovation and development. For instance, the Australian government launched Victorian Cancer Plan 2020-2024 to improve cancer care strategies and cancer outcomes through early detection and timely treatment. In 2019, Barwon Health Foundation collaborated with Varian Medical Systems to inaugurate Andrew Love Cancer Center Chemotherapy Day Ward and Oncology Pharmacy to improve the accessibility of brachytherapy treatment planning solutions. Additionally, in September 2020, the company announced the launch of a new linear accelerator called Elekta Harmony in the market.

However, shortage of healthcare personnel in information technology and radiology sector and cybersecurity and privacy concerns are expected to hinder the market growth during the forecast period.

Brachytherapy Treatment Planning Systems Industry Segmentation

As per the scope of this report, Brachytherapy is a type of internal radiation therapy in which a radiation source is contained in seeds, ribbons, or capsules that are implanted in or near the tumor. The treatment planning system comprises software which used basically in this procedure. Brachytherapy treatment planning is used to determine the optimal source strength or dwell times and source distribution and loading patterns. It is also used to document the isodose distribution, target, and critical organ doses. The system serves as guidance to future patient management. Such systems used in these procedures are called Brachytherapy Treatment Planning Systems. Brachytherapy is a localized treatment that only affects a small area of your body. It is commonly used to treat head and neck cancers, as well as breast, cervical, prostate, and eye malignancies. The Brachytherapy Treatment Planning Systems Market is segmented by Component (Auto-Contouring Software, Multi-Modality Software, PET/CT Deformable Software, and DICOM-RT Software), By Technique (3D Image Reconstruction, In-Room Imaging, and Image Registration using Graphics Processor Unit) and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Component
Auto-Contouring Software
Multi-Modality Software
PET/CT Deformable Software
DICOM-RT Software
By Technique
3D Image Reconstruction
In-Room Imaging
Image Registration using Graphics Processor Unit
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Brachytherapy Treatment Planning Systems Market Size Summary

The Brachytherapy Treatment Planning Systems Market is experiencing significant growth, driven by the increasing prevalence of cancerous disorders and advancements in healthcare infrastructure. The market is characterized by the rising demand for innovative technological solutions in cancer care, particularly in regions like North America, where the availability of advanced healthcare facilities and a favorable reimbursement framework are prominent. The market's expansion is further supported by the growing number of radiation institutes and the development of automated contouring radiotherapy software, which enhances treatment planning and delivery. Key players in the industry are focusing on product innovations and strategic collaborations to improve brachytherapy treatment planning solutions, thereby catering to the increasing cancer burden globally.

Despite challenges such as healthcare personnel shortages and cybersecurity concerns, the market is poised for profitable growth due to supportive government initiatives and public-private partnerships in cancer care. The COVID-19 pandemic initially impacted the market, but the demand for brachytherapy systems is expected to rise with the increase in cardiac surgeries and the ongoing evolution of radiation therapy technologies. The market remains competitive, with major players like Elekta AB, Varian Medical Systems, and MIM Software leading the charge in developing advanced treatment planning systems. As the industry continues to evolve, the focus on patient safety and the integration of digital healthcare solutions are likely to drive further market growth.

Explore More

Global Brachytherapy Treatment Planning Systems Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Investments And Strategic Initiatives In Radiation Therapy and Rising Adoption Of Ai/Ml-c in Oncology Software

      2. 1.2.2 Increasing Prevalence Of Cancer

      3. 1.2.3 Increasing Healthcare IT Expenditure

    3. 1.3 Market Restraints

      1. 1.3.1 Shortage Of Healthcare Personnel In Information Technology And Radiology Sector

      2. 1.3.2 Cybersecurity And Privacy Concerns

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Component

      1. 2.1.1 Auto-Contouring Software

      2. 2.1.2 Multi-Modality Software

      3. 2.1.3 PET/CT Deformable Software

      4. 2.1.4 DICOM-RT Software

    2. 2.2 By Technique

      1. 2.2.1 3D Image Reconstruction

      2. 2.2.2 In-Room Imaging

      3. 2.2.3 Image Registration using Graphics Processor Unit

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global Brachytherapy Treatment Planning Systems Market Size FAQs

The Global Brachytherapy Treatment Planning Systems Market is projected to register a CAGR of 9.30% during the forecast period (2024-2029)

Varian Medical Systems , MIM Software, RaySearch Laboratories, Theragenics Corporation and Elekta are the major companies operating in the Global Brachytherapy Treatment Planning Systems Market.

Brachytherapy Treatment Planning Systems Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)